| 21 September 2020 | Activation of K+–Cl-cotransporter KCC2 by inhibiting the WNK-SPAK kinase signalling as a novel therapeutic strategy for epilepsy
| Zhang, J |
| 28 January 2012 | Characterization of TAE684 as a potent LRRK2 kinase inhibitor
| Zhang, J; Deng, X; Choi, HG; et al. |
| 1 April 2007 | Cloning, expression, and characterization of a cold-adapted lipase gene from an antarctic deep-sea psychorotrophic bacterium, Psychobacter sp. 7195
| Zhang, J; Lin, S; Zeng, R |
| 21 May 2019 | Crossing the Chloride Channel: The Current and Potential Therapeutic Value of the Neuronal K+-Cl- Cotransporter KCC2
| Tillman, L; Zhang, J |
| 15 October 2019 | Developmentally regulated KCC2 phosphorylation is essential for dynamic GABA-mediated inhibition and survival
| Watanabe, M; Zhang, J; Mansuri, MS; et al. |
| 7 July 2012 | GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent- N-arylbenzamide LRRK2 kinase inhibitor
| Reith, AD; Bamborough, P; Jandu, K; et al. |
| 15 October 2019 | Impaired regulation of KCC2 phosphorylation leads to neuronal network dysfunction and neurodevelopmental pathology
| Pisella, LI; Gaiarsa, J-L; Diabira, D; et al. |
| 12 October 2012 | Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
| Yao, C; Johnson, WM; Gao, Y; et al. |
| 7 January 2020 | Modulation of brain cation-Cl− cotransport via the SPAK kinase inhibitor ZT-1a
| Zhang, J; Bhuiyan, MIH; Zhang, T; et al. |
| 18 December 2018 | Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation
| Duran, D; Zeng, X; Jin, SC; et al. |
| 20 August 2020 | New drugs on the horizon for cerebral edema: what’s in the clinical development pipeline?
| Robert, SM; Reeves, BC; Alper, SL; et al. |
| 22 September 2020 | Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension
| Meor Azlan, NF; Koeners, MP; Zhang, J |
| 14 October 2020 | Role of the Cation-chloride-cotransporters in Cardiovascular Disease
| Azlan, NFM; Zhang, J |
| 7 December 2020 | Role of the cation-chloride-cotransporters in the circadian system
| Salihu, S; Azlan, NFM; Josiah, SS; et al. |
| 28 September 2020 | Smoothened receptor signaling regulates the developmental shift of GABA polarity in rat somatosensory cortex.
| Delmotte, Q; Hamze, M; Medina, I; et al. |
| 15 May 2020 | Staurosporine and NEM mainly impair WNK-SPAK/OSR1 mediated phosphorylation of KCC2 and NKCC1
| Zhang, J; Cordshagen, A; Medina, I; et al. |
| 27 January 2021 | Targeting the WNK-SPAK/OSR1 Pathway and Cation-Chloride Cotransporters for the Therapy of Stroke
| Josiah, SS; Meor Azlan, NF; Zhang, J |
| 30 November 2020 | The Therapeutic Potential of Neuronal K-Cl Co-Transporter KCC2 in Huntington’s Disease and Its Comorbidities
| Anfrews, K; Josiah, SS; Zhang, J |
| 28 July 2020 | WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension
| Brown, A; Meor Azlan, NF; Wu, Z; et al. |
